Carl Zeiss Meditec AG (CZMWF)
OTCMKTS
· Delayed Price · Currency is USD
64.88
-0.19 (-0.29%)
Apr 24, 2025, 9:41 AM EDT
Carl Zeiss Meditec AG Revenue
Carl Zeiss Meditec AG had revenue of 490.50M EUR in the quarter ending December 31, 2024, with 3.26% growth. This brings the company's revenue in the last twelve months to 2.08B, down -0.59% year-over-year. In the fiscal year ending September 30, 2024, Carl Zeiss Meditec AG had annual revenue of 2.07B, down -1.11%.
Revenue (ttm)
2.08B EUR
Revenue Growth
-0.59%
P/S Ratio
2.71
Revenue / Employee
363.29K EUR
Employees
5,730
Market Cap
5.85B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 2.07B | -23.17M | -1.11% |
Sep 30, 2023 | 2.09B | 186.46M | 9.80% |
Sep 30, 2022 | 1.90B | 256.05M | 15.55% |
Sep 30, 2021 | 1.65B | 311.33M | 23.31% |
Sep 30, 2020 | 1.34B | -123.87M | -8.49% |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SS Innovations International | 20.65M |
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Northwest Biotherapeutics | 1.38M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 200.90M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Carl Zeiss Meditec AG News
- 6 weeks ago - Carl Zeiss Meditec: Recovery Seems Clear Enough - Seeking Alpha
- 2 months ago - Q1 2025 Carl Zeiss Meditec AG Earnings Call Transcript - GuruFocus
- 5 months ago - Carl Zeiss: Why I Am So Positive - Seeking Alpha
- 7 months ago - My 3 Favorite European Stocks To Diversify Your Portfolio - Seeking Alpha
- 8 months ago - Carl Zeiss: Significant Underperformance, Valuation At Multi-Year Lows - Seeking Alpha
- 9 months ago - Carl Zeiss Meditec AG (CZMWF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Carl Zeiss Meditec: Slightly Better Valuation, Still A Significant Upside - Seeking Alpha
- 1 year ago - Carl Zeiss Meditec AG (CZMWF) Q2 2024 Earnings Call Transcript - Seeking Alpha